These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 11215823)

  • 1. CD21.
    Timens W
    J Biol Regul Homeost Agents; 2000; 14(4):292-4. PubMed ID: 11215823
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of murine complement receptor type 2 (CR2/CD21) ectodomain shedding by its cytoplasmic domain.
    Hoefer MM; Aichem A; Knight AM; Illges H
    Mol Immunol; 2008 Apr; 45(8):2127-37. PubMed ID: 18295335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of CD21 antigen in diffuse large B-cell lymphoma and its clinical significance.
    Otsuka M; Yakushijin Y; Hamada M; Hato T; Yasukawa M; Fujita S
    Br J Haematol; 2004 Nov; 127(4):416-24. PubMed ID: 15521918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection of human B lymphoma cells by Mycoplasma fermentans induces interaction of its elongation factor with the intracytoplasmic domain of Epstein-Barr virus receptor (gp140, EBV/C3dR, CR2, CD21).
    Balbo M; Barel M; Lottin-Divoux S; Jean D; Frade R
    FEMS Microbiol Lett; 2005 Aug; 249(2):359-66. PubMed ID: 16054780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ectodomain shedding and generation of two carboxy-terminal fragments of human complement receptor 2/CD21.
    Hoefer MM; Illges H
    Mol Immunol; 2009 Aug; 46(13):2630-9. PubMed ID: 19524299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD22.
    Engel P
    J Biol Regul Homeost Agents; 2000; 14(4):295-8. PubMed ID: 11215824
    [No Abstract]   [Full Text] [Related]  

  • 7. B cell activation leads to shedding of complement receptor type II (CR2/CD21).
    Masilamani M; Kassahn D; Mikkat S; Glocker MO; Illges H
    Eur J Immunol; 2003 Sep; 33(9):2391-7. PubMed ID: 12938215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EBV attachment stimulates FHOS/FHOD1 redistribution and co-aggregation with CD21: formin interactions with the cytoplasmic domain of human CD21.
    Gill MB; Roecklein-Canfield J; Sage DR; Zambela-Soediono M; Longtine N; Uknis M; Fingeroth JD
    J Cell Sci; 2004 Jun; 117(Pt 13):2709-20. PubMed ID: 15138285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex.
    Rickert RC
    Curr Opin Immunol; 2005 Jun; 17(3):237-43. PubMed ID: 15886112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement receptors CD21 and CD35 in humoral immunity.
    Roozendaal R; Carroll MC
    Immunol Rev; 2007 Oct; 219():157-66. PubMed ID: 17850488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen localization within the splenic marginal zone restores humoral immune response and IgG class switch in complement C4-deficient mice.
    Zachrau B; Finke D; Kropf K; Gosink HJ; Kirchner H; Goerg S
    Int Immunol; 2004 Dec; 16(12):1685-90. PubMed ID: 15477230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ontogeny of the follicular dendritic cell phenotype and function in the postnatal murine spleen.
    Balogh P; Aydar Y; Tew JG; Szakal AK
    Cell Immunol; 2001 Nov; 214(1):45-53. PubMed ID: 11902828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular structure and expression of anthropic, ovine, and murine forms of complement receptor type 2.
    Liu D; Zhu JY; Niu ZX
    Clin Vaccine Immunol; 2008 Jun; 15(6):901-10. PubMed ID: 18400970
    [No Abstract]   [Full Text] [Related]  

  • 14. Improved gene delivery to B lymphocytes using a modified adenovirus vector targeting CD21.
    Mailly L; Renaut L; Rogée S; Grellier E; D'Halluin JC; Colin M
    Mol Ther; 2006 Aug; 14(2):293-304. PubMed ID: 16735140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of IgG antibody responses by epitope density and CD21-mediated costimulation.
    Jegerlehner A; Storni T; Lipowsky G; Schmid M; Pumpens P; Bachmann MF
    Eur J Immunol; 2002 Nov; 32(11):3305-14. PubMed ID: 12555676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-independent B cell-intrinsic and -extrinsic roles for CD21/35.
    Rossbacher J; Haberman AM; Neschen S; Khalil A; Shlomchik MJ
    Eur J Immunol; 2006 Sep; 36(9):2384-93. PubMed ID: 16906534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD37.
    Moldenhauer G
    J Biol Regul Homeost Agents; 2000; 14(4):281-3. PubMed ID: 11215818
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression and role of CR1 and CR2 on B and T lymphocytes under physiological and autoimmune conditions.
    Erdei A; Isaák A; Török K; Sándor N; Kremlitzka M; Prechl J; Bajtay Z
    Mol Immunol; 2009 Sep; 46(14):2767-73. PubMed ID: 19559484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD87.
    Godar S; Stockinger H
    J Biol Regul Homeost Agents; 2000; 14(4):324-6. PubMed ID: 11215831
    [No Abstract]   [Full Text] [Related]  

  • 20. Intrinsic B cell hypo-responsiveness in mice prematurely expressing human CR2/CD21 during B cell development.
    Kulik L; Marchbank KJ; Lyubchenko T; Kuhn KA; Liubchenko GA; Haluszczak C; Gipson MG; Boackle SA; Holers VM
    Eur J Immunol; 2007 Mar; 37(3):623-33. PubMed ID: 17301948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.